Literature DB >> 25959128

Diagnostic value of the rectal ammonia tolerance test, fasting plasma ammonia and fasting plasma bile acids for canine portosystemic shunting.

G van Straten1, B Spee2, J Rothuizen2, M van Straten3, R P Favier2.   

Abstract

Portosystemic shunting (PSS) often results in hyperammonaemia and, consequently, hepatic encephalopathy. This retrospective study evaluated the sensitivity, specificity, positive and negative predictive values (PPV and NPV, respectively) and other test performance metrics for the ammonia tolerance test (ATT), serum fasting bile acids (FBA), serum fasting ammonia concentration (FA), and combinations of these tests for their association with PSS in dogs. Medical records of 271 dogs suspect for PSS (symptomatic group) and 53 dogs returning for evaluation after surgical closure of a congenital PSS (CPSS post-surgical control group) were analysed. In the symptomatic group, ATT at 40 min (T40), and the FBA had the highest sensitivity (100% and 98%, respectively) and NPV (100% and 96%, respectively) for PSS. The combination of increased FBA and FA had the highest specificity (97%), with a PPV of 97%, and a positive likelihood ratio of 29. In the CPSS post-surgical control group, the specificity and PPV of FA and the combination of increased FBA/FA were both 100%. In purebred populations, the NPV of all tests was 100%. Consequently, PSS would be ruled out in a symptomatic dog with normal FBA or ATT (T40) and would be highly probable when both FBA and FA are increased. Increased FA was conclusive for PSS in dogs evaluated for post-surgical closure of a CPSS. FBA was the most suitable test for screening purposes.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ammonia tolerance test; Congenital portosystemic shunt; Fasting ammonia concentrations; Fasting bile acids; Predictive values

Mesh:

Substances:

Year:  2015        PMID: 25959128     DOI: 10.1016/j.tvjl.2015.04.020

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  9 in total

1.  Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs.

Authors:  K Dirksen; T Verzijl; G C Grinwis; R P Favier; L C Penning; I A Burgener; L J van der Laan; H Fieten; B Spee
Journal:  J Vet Intern Med       Date:  2016-11-11       Impact factor: 3.333

2.  Aberrant hepatic lipid storage and metabolism in canine portosystemic shunts.

Authors:  Lindsay Van den Bossche; Vivien A C Schoonenberg; Iwan A Burgener; Louis C Penning; Ingrid M Schrall; Hedwig S Kruitwagen; Monique E van Wolferen; Guy C M Grinwis; Anne Kummeling; Jan Rothuizen; Jeroen F van Velzen; Nikolas Stathonikos; Martijn R Molenaar; Bernd J Helms; Jos F H M Brouwers; Bart Spee; Frank G van Steenbeek
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

3.  Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers.

Authors:  K Dirksen; I A Burgener; J Rothuizen; T S G A M van den Ingh; L C Penning; B Spee; H Fieten
Journal:  J Vet Intern Med       Date:  2017-05-23       Impact factor: 3.333

4.  Saline is as effective as nitrogen scavengers for treatment of hyperammonemia.

Authors:  G van Straten; M G M de Sain-van der Velden; I M van Geijlswijk; R P Favier; S J Mesu; N E Holwerda-Loof; M van der Ham; H Fieten; J Rothuizen; B Spee; N M Verhoeven-Duif
Journal:  Sci Rep       Date:  2017-10-13       Impact factor: 4.379

5.  Untargeted metabolomic profiling of urine from healthy dogs and dogs with chronic hepatic disease.

Authors:  Yuri A Lawrence; Blake C Guard; Jörg M Steiner; Jan S Suchodolski; Jonathan A Lidbury
Journal:  PLoS One       Date:  2019-05-31       Impact factor: 3.240

6.  Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts.

Authors:  Giora van Straten; Diewke van Dalen; Sietske J Mesu; Jan Rothuizen; Erik Teske; Bart Spee; Robert P Favier; Ingeborg M van Geijlswijk
Journal:  J Vet Intern Med       Date:  2019-03-27       Impact factor: 3.333

7.  Evaluation of serum lidocaine/monoethylglycylxylidide concentration to assess shunt closure in dogs with extrahepatic portosystemic shunts.

Authors:  Nausikaa Devriendt; Gonçalo Serrano; Siska Croubels; Emmelie Stock; Eva Vandermeulen; Dominique Paepe; Jennifer von Luckner; Hilde de Rooster
Journal:  J Vet Intern Med       Date:  2021-01-12       Impact factor: 3.175

8.  Genome-wide based model predicting recovery from portosystemic shunting after liver shunt attenuation in dogs.

Authors:  Lindsay Van den Bossche; Frank G van Steenbeek; Maarten F Weber; Bart Spee; Louis C Penning; Freek J van Sluijs; Flin Zomerdijk; Marian J A Groot Koerkamp; Jan Rothuizen; Iwan A Burgener; Anne Kummeling
Journal:  J Vet Intern Med       Date:  2018-05-17       Impact factor: 3.333

9.  Resolution of Severe Neurologic Signs Following Intravenous Lipid Emulsion Therapy in a Young Dog With a Portosystemic Shunt: Case Report.

Authors:  Amanda M Spillane; Jenica L Haraschak; Maureen A McMichael
Journal:  Front Vet Sci       Date:  2021-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.